How many employees does Axsome Therapeutics, Inc. have?

Axsome Therapeutics, Inc. reported 925 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 23, 2026. That is up 35.4% from a year earlier.

What is Axsome Therapeutics, Inc.'s revenue per employee?

Axsome Therapeutics, Inc. brought in $638M of revenue in fiscal Dec 2025, which is $690K per employee. That ranks 18 of 39 companies we track in Biotechnology, where the median is $602K.

Is Axsome Therapeutics, Inc. hiring?

Axsome Therapeutics, Inc.'s public job board listed 92 open roles on October 7, 2026, about 99 per 1,000 staff.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Axsome Therapeutics, Inc. employees and revenue per employee

AXSM · Biotechnology · $9.22B market cap

Axsome Therapeutics, Inc. had 925 employees at the end of fiscal Dec 2025, up 35.4% from a year earlier. Revenue for the year was $638M, up 65.5% from a year earlier, or $690K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

925

+35.4% YoY

Revenue

$638M

+65.5% YoY

Revenue / employee

$690K

Peer median $602K

Rank in industry

18 of 39

Biotechnology

Open roles

99 per 1,000 staff

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2022

Hover a year for the numbers.

AXSM employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	925	$638M	$690K	+35.4%	+65.5%
Dec 2024	683	$386M	$565K	+25.3%	+42.5%
Dec 2023	545	$271M	$497K	+42.3%	+440.8%
Dec 2022	383	$50.0M	$131K	—	—

Open roles on its job board: 92 (99 per 1,000 staff, against its latest annual headcount), as of 2026-10-07. Tracked since 2026-10-03. No 90 day change yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Axsome Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
BCRX BioCryst Pharmaceuticals, Inc.	435	$875M	$2.01M	Leaner
TGTX TG Therapeutics, Inc.	399	$616M	$1.54M	Efficient growth
ARWR Arrowhead Pharmaceuticals, Inc.	711	$829M	$1.17M	Efficient growth
ADMA ADMA Biologics, Inc.	647	$510M	$789K	Leaner
AXSM Axsome Therapeutics, Inc.	925	$638M	$690K	Efficient growth
IONS Ionis Pharmaceuticals, Inc.	1,402	$944M	$673K	Efficient growth
BBIO BridgeBio Pharma, Inc.	834	$502M	$602K	Efficient growth
TXG 10x Genomics, Inc.	1,178	$643M	$546K	Leaner
INSM Insmed Incorporated	1,664	$606M	$364K	Efficient growth

Every Healthcare company

Questions about Axsome Therapeutics, Inc.

How many employees does Axsome Therapeutics, Inc. have?: Axsome Therapeutics, Inc. reported 925 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 23, 2026. That is up 35.4% from a year earlier.
What is Axsome Therapeutics, Inc.'s revenue per employee?: Axsome Therapeutics, Inc. brought in $638M of revenue in fiscal Dec 2025, which is $690K per employee. That ranks 18 of 39 companies we track in Biotechnology, where the median is $602K.
Is Axsome Therapeutics, Inc. hiring?: Axsome Therapeutics, Inc.'s public job board listed 92 open roles on October 7, 2026, about 99 per 1,000 staff.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare AXSM with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Axsome Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 23, 2026. This is data, not a recommendation to buy or sell AXSM.